Tildrakizumab efficacy for psoriatic arthritis: 24-week analysis of swollen and tender joint counts and pain

被引：0

作者：

Espinoza, Luis R. ^{[1
]}

Ballerini, Rocco ^{[2
]}

Chou, Richard ^{[3
]}

Rozzo, Stephen J. ^{[4
]}

Mendelsohn, Alan M. ^{[4
]}

机构：

[1] Louisiana State Univ, Rheumatol Sect, Hlth Sci Ctr, New Orleans, LA USA

[2] Sun Pharma Adv Res Co Ltd, Mumbai, Maharashtra, India

[3] SUNY Buffalo, Buffalo, NY USA

[4] Sun Pharma, Mumbai, Maharashtra, India

来源：

JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2020年 / 83卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100206 ;

摘要：

15994

引用

页码：AB166 / AB166

页数：1

共 50 条

[31] INTRAVENOUS GOLIMUMAB IN ADULT PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: EFFICACY AND SAFETY THROUGH WEEK 24
Kavanaugh, A.
Husni, M. E.
Harrison, D. D.
Kim, L.
Lo, K. H.
Hsia, E. C.
ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 671 - 672
[32] Efficacy and Safety of Neihulizumab (AbGn-168H) in Patients with Active Psoriatic Arthritis: 24-week Results from a Phase II Open Label Study
Cohen, Stanley
Fiechtner, Justus
Mease, Philip
Kaine, Jeffrey
Kavanaugh, Arthur
Cheng, Yi-Lin
Chou, Claire
Cheng, Ting-Ying
Lin, Shih-Yao
Genovese, Mark
ARTHRITIS & RHEUMATOLOGY, 2020, 72
[33] The Predictive Value of Patient's and Evaluator's Global Assessment and Tender and Swollen Joint Count Differences on Treatment Efficacy in Psoriatic Arthritis: Data from a Longitudinal Multicenter Study
Michelsen, Brigitte
Kristianslund, Eirik K.
Hammer, Hilde B.
Fagerli, Karen M.
Lie, Elisabeth
Haugeberg, Glenn
Kvien, Tore K.
ARTHRITIS & RHEUMATOLOGY, 2016, 68
[34] Efficacy of Upadacitinib in Patients with Active Psoriatic Arthritis and a Low or High Swollen Joint Count: A Subgroup Analysis of 2 Phase 3 Studies
Gossec, Laure
Gladman, Dafna
McDearmon-Blondell, Erin
Sewerin, Philipp
Ritchlin, Christopher
Feng, Dai
Lertratanakul, Apinya
Ranza, Roberto
Tam, Lai-Shan
Marchesoni, Antonio
Coates, Laura
Nash, Peter
ARTHRITIS & RHEUMATOLOGY, 2021, 73 : 3805 - 3808
[35] Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study
Maddalena Napolitano
Luisa Costa
Francesco Caso
Matteo Megna
Raffaele Scarpa
Nicola Balato
Fabio Ayala
Anna Balato
Clinical Rheumatology, 2017, 36 : 1589 - 1593
[36] Minimal disease activity in patients with psoriatic arthritis treated with ustekinumab: results from a 24-week real-world study
Napolitano, Maddalena
Costa, Luisa
Caso, Francesco
Megna, Matteo
Scarpa, Raffaele
Balato, Nicola
Ayala, Fabio
Balato, Anna
CLINICAL RHEUMATOLOGY, 2017, 36 (07) : 1589 - 1593
[37] Brodalumab in psoriatic arthritis (PsA): 24-week results from the phase III AMVISON-1 and-2 trials
McInnes, Iain
Mease, Philip
Hjuler, Kasper Fjellhaugen
Raymond, Kyle
Helliwell, Philip
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB28 - AB28
[38] TOWARDS DEVELOPMENT OF AN ULTRASOUND ENTHESITIS SCORE IN PSORIATIC ARTHRITIS: 24-WEEK RESULTS FROM THE PHASE III RANDOMISED ULTIMATE STUDY
D'agostino, M. A.
Conaghan, P. G.
Gaillez, C.
Boers, M.
Naredo, E.
Carron, P.
Hanova, P.
Cazenave, T.
Bakewell, C.
Duggan, A. M.
Goyanka, P.
Schett, G.
ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 136 - 137
[39] 24-Week study on the use of collagen hydrolysate as a dietary supplement in athletes with activity-related joint pain
Clark, Kristine L.
Sebastianelli, Wayne
Flechsenhar, Klaus R.
Aukermann, Douglas F.
Meza, Felix
Millard, Roberta L.
Deitch, John R.
Sherbondy, Paul S.
Albert, Ann
CURRENT MEDICAL RESEARCH AND OPINION, 2008, 24 (05) : 1485 - 1496
[40] OPEN LABELED, MULTICENTER 24-WEEK STUDY TO ASSESS THE EFFICACY AND SAFETY OF TACROBELL® IN ACTIVE RHEUMATOID ARTHRITIS PATIENTS
Hong, S. -J.
Choi, J. -Y.
Kim, S. -S.
Kim, Y. S.
Kim, S. -H.
Kim, G. -T.
Choi, S. J.
Lee, M. S.
Hur, J. -W.
ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1043 - 1043

← 1 2 3 4 5 →